Drug - Nulojix (belatacept) [BMS]
Therapeutic area - Immunosuppression
- Patient has received a kidney transplant AND
- Patient is EBV seropositive
NULOJIX is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant. Use is only approved in patients who are EBV seropositive and kidney transplant.
MHCP Provider Call Center 651-431-2700 or 800-366-5411